These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
231 related articles for article (PubMed ID: 31601401)
1. Calcineurin signaling as a target for the treatment of alcohol abuse and neuroinflammatory disorders. Ronan PJ; Flynn SA; Beresford TP Prog Mol Biol Transl Sci; 2019; 167():125-142. PubMed ID: 31601401 [TBL] [Abstract][Full Text] [Related]
2. Neuroimmune signaling in alcohol use disorder. Erickson EK; Grantham EK; Warden AS; Harris RA Pharmacol Biochem Behav; 2019 Feb; 177():34-60. PubMed ID: 30590091 [TBL] [Abstract][Full Text] [Related]
3. Pharmacotherapy for Co-Occurring Alcohol Use Disorder and Post-Traumatic Stress Disorder: Targeting the Opioidergic, Noradrenergic, Serotonergic, and GABAergic/Glutamatergic Systems. Verplaetse TL; McKee SA; Petrakis IL Alcohol Res; 2018; 39(2):193-205. PubMed ID: 31198658 [TBL] [Abstract][Full Text] [Related]
4. Pre-clinical evidence that corticotropin-releasing factor (CRF) receptor antagonists are promising targets for pharmacological treatment of alcoholism. Lowery EG; Thiele TE CNS Neurol Disord Drug Targets; 2010 Mar; 9(1):77-86. PubMed ID: 20201818 [TBL] [Abstract][Full Text] [Related]
5. N-3 polyunsaturated fatty acids in animal models with neuroinflammation: An update. Trépanier MO; Hopperton KE; Orr SK; Bazinet RP Eur J Pharmacol; 2016 Aug; 785():187-206. PubMed ID: 26036964 [TBL] [Abstract][Full Text] [Related]
6. Relationship between sphingolipids-mediated neuroinflammation and alcohol use disorder. Cui X; Li J; Wang C; Ishaq HM; Zhang R; Yang F Pharmacol Biochem Behav; 2024 Feb; 235():173695. PubMed ID: 38128765 [TBL] [Abstract][Full Text] [Related]
7. Relationship between the chemokine receptor CCR5 and microglia in neurological disorders: consequences of targeting CCR5 on neuroinflammation, neuronal death and regeneration in a model of epilepsy. Louboutin JP; Strayer DS CNS Neurol Disord Drug Targets; 2013 Sep; 12(6):815-29. PubMed ID: 24047524 [TBL] [Abstract][Full Text] [Related]
8. Early Life Stress as a Predictor of Co-Occurring Alcohol Use Disorder and Post-Traumatic Stress Disorder. Lee RS; Oswald LM; Wand GS Alcohol Res; 2018; 39(2):147-159. PubMed ID: 31198654 [TBL] [Abstract][Full Text] [Related]
9. On the Neurobiological Role of Oxidative Stress in Alcohol-Induced Impulsive, Aggressive and Suicidal Behavior. Tobore TO Subst Use Misuse; 2019; 54(14):2290-2303. PubMed ID: 31369300 [No Abstract] [Full Text] [Related]
10. Contribution of Urocortin to the Development of Excessive Drinking. Ryabinin AE; Giardino WJ Int Rev Neurobiol; 2017; 136():275-291. PubMed ID: 29056154 [TBL] [Abstract][Full Text] [Related]
11. Randomized controlled trial of cognitive behaviour therapy for comorbid post-traumatic stress disorder and alcohol use disorders. Sannibale C; Teesson M; Creamer M; Sitharthan T; Bryant RA; Sutherland K; Taylor K; Bostock-Matusko D; Visser A; Peek-O'Leary M Addiction; 2013 Aug; 108(8):1397-1410. PubMed ID: 25328957 [TBL] [Abstract][Full Text] [Related]
12. Epigenetic mechanisms of alcoholism and stress-related disorders. Palmisano M; Pandey SC Alcohol; 2017 May; 60():7-18. PubMed ID: 28477725 [TBL] [Abstract][Full Text] [Related]
13. Targeting NPY, CRF/UCNs and NPS Neuropeptide Systems to Treat Alcohol Use Disorder (AUD). Rodriguez FD; Coveñas R Curr Med Chem; 2017; 24(23):2528-2558. PubMed ID: 28302012 [TBL] [Abstract][Full Text] [Related]
14. Its complicated: The relationship between alcohol and microglia in the search for novel pharmacotherapeutic targets for alcohol use disorders. Melbourne JK; Thompson KR; Peng H; Nixon K Prog Mol Biol Transl Sci; 2019; 167():179-221. PubMed ID: 31601404 [TBL] [Abstract][Full Text] [Related]
15. Comorbid post-traumatic stress disorder in alcohol use disorder: relationships to demography, drinking and neuroimmune profile. Neupane SP; Bramness JG; Lien L BMC Psychiatry; 2017 Aug; 17(1):312. PubMed ID: 28851339 [TBL] [Abstract][Full Text] [Related]
16. Persistent adaptation by chronic alcohol is facilitated by neuroimmune activation linked to stress and CRF. Breese GR; Knapp DJ Alcohol; 2016 May; 52():9-23. PubMed ID: 27139233 [TBL] [Abstract][Full Text] [Related]
17. Targeting the intracellular signaling "STOP" and "GO" pathways for the treatment of alcohol use disorders. Ron D; Berger A Psychopharmacology (Berl); 2018 Jun; 235(6):1727-1743. PubMed ID: 29654346 [TBL] [Abstract][Full Text] [Related]
19. Molecular Mechanisms of Curcumin in Neuroinflammatory Disorders: A Mini Review of Current Evidences. Hatami M; Abdolahi M; Soveyd N; Djalali M; Togha M; Honarvar NM Endocr Metab Immune Disord Drug Targets; 2019; 19(3):247-258. PubMed ID: 30488803 [TBL] [Abstract][Full Text] [Related]
20. Altered Neuroinflammation and Behavior after Traumatic Brain Injury in a Mouse Model of Alzheimer's Disease. Kokiko-Cochran O; Ransohoff L; Veenstra M; Lee S; Saber M; Sikora M; Teknipp R; Xu G; Bemiller S; Wilson G; Crish S; Bhaskar K; Lee YS; Ransohoff RM; Lamb BT J Neurotrauma; 2016 Apr; 33(7):625-40. PubMed ID: 26414955 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]